Heart rate variability and sensorimotor polyneuropathy in type 1 diabetes

Diabetes Care

Volumn 35, Issue 4, 2012, Pages 809-816

  Orlov, Steven ^a   Bril, Vera ^a   Orszag, Andrej ^a   Perkins, Bruce A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; ARTICLE; BREATHING RATE; CAUSAL ATTRIBUTION; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FUNCTIONAL ASSESSMENT; HEART RATE VARIABILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROMORPHOLOGY; POLYNEUROPATHY; PROGNOSIS; SENSORIMOTOR NEUROPATHY; SMALL FIBER NEUROPATHY; SYSTOLIC BLOOD PRESSURE; VALIDATION PROCESS;

ADULT; ARRHYTHMIAS, CARDIAC; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; RESPIRATION; YOUNG ADULT;

EID: 84862109679     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1652     Document Type: Article

References (40)

1. Murray A, Ewing DJ, Campbell IW, Neilson JM, Clarke BF. RR interval variations in young male diabetics. Br Heart J 1975;37:882-885
2. Dyck JB, Dyck PJ. Diabetic polyneuropathy. In Diabetic Neuropathy. Dyck PJ, Thomas PK, Eds. Philadelphia, W.B. Saunders, 1999, p. 255-278
3. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980;49:95-108 (Pubitemid 10039105)
4. Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care 2010;33:434-441
5. Spallone V, Ziegler D, Freeman R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. In press
6. Tesfaye S, Boulton AJ, Dyck PJ, et al.; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33:2285-2293
7. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553-1579 (Pubitemid 36934465)
8. Young LH, Wackers FJ, Chyun DA, et al.; DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 2009;301:1547-1555
9. Pop-Busui R, Evans GW, Gerstein HC, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010;33:1578-1584
10. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003;26:1895-1901 (Pubitemid 36929140)
11. Ziegler D, Zentai CP, Perz S, et al.; KORA Study Group. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care 2008;31:556-561
12. Wheeler SG, Ahroni JH, Boyko EJ. Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes. Diabetes Res Clin Pract 2002; 58:131-138
13. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 1998;41:416-423
14. Pop-Busui R, Low PA, Waberski BH, et al.; DCCT/EDIC Research Group. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation 2009;119:2886-2893
15. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 1999;353:617-622 (Pubitemid 29087981)
16. Brotman DJ, Bash LD, Qayyum R, et al. Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol 2010;21:1560-1570
17. Chandra P, Sands RL, Gillespie BW, et al. Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol Dial Transplant. In press
18. Ziegler D, Dannehl K, Mühlen H, Spüler M, Gries FA. Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy. Diabet Med 1992;9:806-814
19. Hertz P, Bril V, Orszag A, et al. Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabet Med 2011;1253-1260
20. England JD, Gronseth GS, Franklin G, et al.; American Academy of Neurology; American Association of Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005;64:199-207
21. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 2001;24:250-256 (Pubitemid 32119120)
22. Stålberg EV, Nogués MA. Automatic analysis of heart rate variation: I. Method and reference values in healthy controls. Muscle Nerve 1989;12:993-1000 (Pubitemid 20010758)
23. Oh SJ. Normal values for common nerve conduction tests. In Clinical Electromyography: Nerve Conduction Studies. 3rd ed. Philadelphia, Lipincott Williams & Wilkins, 2003, p. 86-106
24. Tavakoli M, Malik RA. Corneal confocal microscopy: a novel non-invasive technique to quantify small fibre pathology in peripheral neuropathies. J Vis Exp. In press
25. Zinman LH, Bril V, Perkins BA. Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instruments. Diabetes Care 2004;27:1674-1679 (Pubitemid 38857443)
26. flare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes. Diabetes Care 2004;27:2930-2935
27. Cardoso CR, Leite NC, Freitas L, Dias SB, Muxfeld ES, Salles GF. Pattern of 24-hour ambulatory blood pressure monitoring in type 2 diabetic patients with cardiovascular dysautonomy. Hypertens Res 2008;31:865-872 (Pubitemid 351895030)
28. Veglio M, Chinaglia A, Cavallo-Perin P. QT interval, cardiovascular risk factors and risk of death in diabetes. J Endocrinol Invest 2004;27:175-181 (Pubitemid 38514812)
29. Lykke JA, Tarnow L, Parving HH, Hilsted J. A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes. Scand J Clin Lab Invest 2008;68:654-659
30. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007;115:387-397 (Pubitemid 46148513)
31. Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH; EURODIAB Prospective Complications Study Group. Risk factors for cardiac autonomic neuropathy in type 1 diabetesmellitus. Diabetologia 2005;48:164-171 (Pubitemid 40174669)
32. Ayad F, Belhadj M, Pariés J, Attali JR, Valensi P. Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications. Diabet Med 2010;27:804-811
33. Gelber DA, Pfeifer M, Dawson B, Schumer M. Cardiovascular autonomic nervous system tests: determination of normative values and effect of confounding variables. J Auton Nerv Syst 1997;62:40-44 (Pubitemid 27043082)
34. Kempler P, Tesfaye S, Chaturvedi N, et al.; EURODIAB IDDM Complications Study Group. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med 2002;19:900-909 (Pubitemid 35356915)
35. Stella P, Ellis D, Maser RE, Orchard TJ. Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors. J Diabetes Complications 2000;14:1-6 (Pubitemid 30484031)
36. Valensi P, Pariès J, Attali JR; French Group for Research and Study of Diabetic Neuropathy. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications - the French multicenter study. Metabolism 2003;52:815-820 (Pubitemid 36949541)
37. Valensi P, Extramiana F, Lange C, et al.; DESIR Study Group. Influence of blood glucose on heart rate and cardiac autonomic function. The DESIR study. Diabet Med 2011;28:440-449
38. Shahani BT, Day TJ, Cros D, Khalil N, Kneebone CS. RR interval variation and the sympathetic skin response in the assessment of autonomic function in peripheral neuropathy. Arch Neurol 1990;47:659-664 (Pubitemid 20183576)
39. Spitzer A, Lang E, Birklein F, Claus D, Neundörfer B. Cardiac autonomic involvement and peripheral nerve function in patients with diabetic neuropathy. Funct Neurol 1997;12:115-122 (Pubitemid 27339291)
40. Weinberg CR, Pfeifer MA. An improved method for measuring heart-rate variability: assessment of cardiac autonomic function. Biometrics 1984;40:855-861